The past week has brought a steady flow of signals from major global regulators, offering a snapshot of how oversight is ...

US genetic medicine company Sarepta Therapeutics has announced an update to the prescribing information for Elevidys ...

Dutch clinical-stage cancer drug developer Merus, which is developing innovative, full-length multi-specific antibodies and ...

Canada-based clinical-stage biotech Zymeworks today announced positive top-line results from the Phase III HERIZON-GEA-01 ...

The European Federation of Pharmaceuticals Industries and Associations (EFPIA) and Vaccine Europe (VE) are calling for clear, ...

Established by ADQ, an active sovereign investor focused on critical infrastructure and global supply chains, Arcera is ...

Sofinnova Partners, a European life sciences venture capital firm based in Paris, London and Milan, today announced the close ...

Belgium-based Agomab Therapeutics today announced positive data from 103 participants completing 12 weeks of treatment in the ...

Export Barbados (BIDC) and EarlyHealth Group (EHG), headquartered in Dubai, United Arab Emirates, have signed a Letter of Intent to jointly establish EarlyHealth City Barbados, a $200 million ...

Last week saw the end of the bidding war for Metsera, with the company accepting an improved offer from Pfizer and counter ...

The European Medicines Agency’s EMA’s human medicines committee (CHMP) recommended seven novel medicines for approval at its ...

Between the US government shutdown, crippling international tariffs, debilitating funding cuts to critical research, and the ...